


Pharmaceuticals & Biotechnology | Small Cap
Medicamen Organics Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strength in solvency, growth, and profitability, indicating a solid foundation and good earning potential. However, liquidity and efficiency ratios suggest areas needing attention. While the company is growing its revenue and profits impressively, it struggles with converting assets into sales and maintaining sufficient liquid assets to cover its short-term liabilities. Overall, Medicamen Organics is a company with high growth and profitability potential, but it needs to manage its assets and liabilities more efficiently to ensure long-term financial health. There are opportunities for improvement in managing working capital and enhancing operational efficiency.
Medicamen Organics Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strength in solvency, growth, and profitability, indicating a solid foundation and good earning potential. However, liquidity and efficiency ratios suggest areas needing attention. While the company is growing its revenue and profits impressively, it struggles with converting assets into sales and maintaining sufficient liquid assets to cover its short-term liabilities. Overall, Medicamen Organics is a company with high growth and profitability potential, but it needs to manage its assets and liabilities more efficiently to ensure long-term financial health. There are opportunities for improvement in managing working capital and enhancing operational efficiency.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-10.80
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
-8.18
P/B RATIO
1.14
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
1.49
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
0.00
EV/EBITDA RATIO
-9.13
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹27 as on Aug 6, 2026.
The growth ratios indicate strong growth. High revenue growth, operating profit growth, EPS growth, and net income growth rates suggest the company is expanding its business and increasing its profitability. The asset growth rate, however, is concerning. Overall, the company is experiencing robust growth in key areas, indicating positive momentum and future potential.
| Growth Ratios | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue Growth Rate | 51.13 | -40.74 | |
| Operating Profit Growth Rate | 39.45 | -156.73 | |
| Earnings Per Share (EPS) Growth | 13.44 | -195.38 | |
| Asset Growth Rate | 54.03 | -12.8 | |
| Net Income Growth Rate | 54.58 | -199.26 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medicamen Organics Ltd | 6.30 | -8.18 | Neutral | -3.75 | -2.50 | -4.02 |
| 2 | Mono Pharmacare Ltd | 6.16 | 4.71 | Neutral | 8.00 | 1.75 | 3.00 |
| 3 | JFL Life Sciences Ltd | 6.07 | 13.51 | Neutral | 12.00 | 1.94 | 6.00 |
| 4 | Walpar Nutritions Ltd | 5.29 | 13.25 | Neutral | 6.66 | 2.09 | 3.00 |
| 5 | Mangalam Drugs and Organics Ltd | 4.50 | -0.97 | Neutral | -15.00 | -27.68 | -44.00 |
| 6 | Lasa Supergenerics Ltd | 4.39 | -2.61 | Highly Undervalued | -7.00 | -6.80 | -34.00 |
| 7 | Sunrest Lifescience Ltd | 4.17 | 8.13 | Highly Undervalued | 10.21 | 3.60 | 8.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish